-
Mashup Score: 2TENS Treatment Improves Pressure Pain Thresholds in Fibromyalgia - 11 month(s) ago
Results indicate the potential relevance of pressure pain thresholds for understanding the mechanisms that contribute to pain in fibromyalgia.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 5Early Menopause Significantly Increases Risk of Developing RA - 11 month(s) ago
Entering menopause prior to age 45 was associated with a 46% increased risk of developing RA compared with those who began menopause at ≥50 years.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
Entering #menopause before age 45 was associated with a 46% increased risk of developing #RheumatoidArthritis compared with those who began menopause at ≥50 years. Learn more: https://t.co/Jqp6xDNEIm
-
-
Mashup Score: 1Rheumatology Month in Review: December 2023 - 11 month(s) ago
The rheumatology month in review highlights fibromyalgia complexities, lupus advancements, and dietary links to gout for improved management.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
The rheumatology month in review highlights #fibromyalgia complexities, #lupus advancements, and dietary links to #gout for improved management. Check it out: https://t.co/ZfoQDSKZDZ
-
-
Mashup Score: 2TENS Treatment Improves Pressure Pain Thresholds in Fibromyalgia - 11 month(s) ago
Results indicate the potential relevance of pressure pain thresholds for understanding the mechanisms that contribute to pain in fibromyalgia.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
Results indicate the potential relevance of pressure pain thresholds for understanding the mechanisms that contribute to pain in #fibromyalgia. https://t.co/Hc171aiRxo
-
-
Mashup Score: 1GERD Diagnosis Significantly Increases Risk of Concomitant RA - 11 month(s) ago
Results indicated patients with GERD are at a 69% increased risk of developing RA.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
Results indicated patients with GERD are at a 69% increased risk of developing #RheumatoidArthritis. Learn more: https://t.co/GPssYSUIzI
-
-
Mashup Score: 0Aflibercept Biosimilar SB15 Demonstrates Comparable Efficacy, Safety - 11 month(s) ago
Efficacy, pharmacokinetics, immunogenicity, and safety were comparable between patients receiving the aflibercept biosimilar SB15 and the reference drug.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
Efficacy, pharmacokinetics, immunogenicity, and safety were comparable between patients receiving the #aflibercept #biosimilar SB15 and the reference drug. https://t.co/Cu5Uxoq0zB
-
-
Mashup Score: 0Biosimilars Month in Review: December 2023 - 11 month(s) ago
The biosimilars month in review highlights interviews with experts discussing the cost-saving potential of increased biosimilars uptake in the US, a recent US Food and Drug Administration (FDA) approval, and the impact of a mandatory switch to an adalimumab biosimilar in New Zealand.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
The biosimilars month in review highlights interviews with experts discussing the cost-saving potential of increased #biosimilars uptake in the US, a recent FDA approval, and the impact of a mandatory switch to an adalimumab #biosimilar in New Zealand. https://t.co/BkVW654YDP
-
-
Mashup Score: 0Biosimilars Month in Review: December 2023 - 11 month(s) ago
The biosimilars month in review highlights interviews with experts discussing the cost-saving potential of increased biosimilars uptake in the US, a recent US Food and Drug Administration (FDA) approval, and the impact of a mandatory switch to an adalimumab biosimilar in New Zealand.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
The biosimilars month in review highlights interviews with experts discussing the cost-saving potential of increased #biosimilars uptake in the US, a recent FDA approval, and the impact of a mandatory switch to an adalimumab #biosimilar in New Zealand. https://t.co/BkVW654YDP
-
-
Mashup Score: 0Rheumatology Month in Review: December 2023 - 11 month(s) ago
The rheumatology month in review highlights fibromyalgia complexities, lupus advancements, and dietary links to gout for improved management.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
The rheumatology month in review highlights #fibromyalgia complexities, #lupus advancements, and dietary links to #gout for improved management. Check it out: https://t.co/ZfoQDSKZDZ
-
-
Mashup Score: 0Study Examines Factors Impacting Health-Related Quality of Life in Male Patients with Gout - 11 month(s) ago
Various factors related to demographics, psychosocial behavior variables, and clinical characteristics were linked to health-related quality of life in patients with gout.
Source: www.hcplive.comCategories: General Medicine News, RheumatologyTweet-
Various factors related to demographics, psychosocial behavior variables, and clinical characteristics were linked to health-related quality of life in patients with #gout. https://t.co/wOEayt0tgF
-
Results indicate the potential relevance of pressure pain thresholds for understanding the mechanisms that contribute to pain in #fibromyalgia. https://t.co/Hc171aiRxo